Study on the Model of Smoking Cessation Intervention and Service Ability Improvement

NCT01935505 | Unknown DMC

• 1 other identifier: IGPLAGH301YaoHe
• Study Type: observational
• Target: 2,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

This is a observation non-randomized control trial, and a follow-up study on the smoking cessation.

Conditions

Smoking Cessation

Keywords

smoking cessation; intervention model; Chinese; quitting rate

Outcome Measures

Primary Outcomes (1)

• quitting rate

  The whole project will last for 10 years in total, from Oct.2008 to Dec.2018. During the running, each participant will be followed by telephone tracking, an expected average of 2 years.

  up to 10 years

Secondary Outcomes (1)

• decrease of tobacco consumption

  up to 10 years

Other Outcomes (1)

• changes of Knowledge Attitude and Practice

  up to 10 years

Study Arms (4)

Consulting group

The physicians adopted a non-directive approach, included the five 'A' (ask, advice, assess, assist and arrange), assessing the stage of readiness in quitting smoking, strengthening clients' motivation to quit smoking using the five 'R' (relevance, risks, rewards, roadblocks and repetition) approach, and providing advice to overcome psychological craving, psychological dependence and social-cultural factors associated with tobacco dependency. Each smoker takes more than 30 min to complete the intervention.

Behavioral: Consulting

Drug intervention group

According to the smokers' level of nicotine dependency, disease history, cigarette consumption, prescription of drugs were provided, Nicotine Replacement Therapy, bupropion and varenicline.

Behavioral: Consulting; Drug: Nicotine patch; Behavioral: Telephone intervention

Telephone intervention group

Smokers received follow-up by a counselor at 1 week, 1, 3, 6 months and 1, 2 years using a detailed questionnaire by telephone interview. At each follow-up, we collected data, asked whether the smokers have any problem with drug use or other problems, provided problem-oriented suggestions or advice as appropriate, encouraged them to insist.

Behavioral: Consulting; Behavioral: Telephone intervention

Consulting+Telephone+Drug intervention

All the interventions above are include in this group

Behavioral: Consulting+Telephone+Drug intervention

Interventions

Consulting BEHAVIORAL

The physicians adopted a non-directive approach, included the five 'A' (ask, advice, assess, assist and arrange), assessing the stage of readiness in quitting smoking, strengthening clients' motivation to quit smoking using the five 'R' (relevance, risks, rewards, roadblocks and repetition) approach, and providing advice to overcome psychological craving, psychological dependence and social-cultural factors associated with tobacco dependency. Each smoker takes more than 30 min to complete the intervention.

Consulting group; Drug intervention group; Telephone intervention group

Nicotine patch DRUG

According to the smokers' level of nicotine dependency, disease history, cigarette consumption, prescription of drugs were provided, Nicotine Replacement Therapy, bupropion and varenicline.

Also known as: Nicotine Replacement Therapy: Nicotine patch, bupropion, varenicline

Drug intervention group

Telephone intervention BEHAVIORAL

Smokers received follow-up by a counselor at 1 week, 1, 3, 6 months and 1, 2 years using a detailed questionnaire by telephone interview. At each follow-up, we collected data, asked whether the smokers have any problem with drug use or other problems, provided problem-oriented suggestions or advice as appropriate, encouraged them to insist.

Drug intervention group; Telephone intervention group

Consulting+Telephone+Drug intervention BEHAVIORAL

Include all the above interventions

Consulting+Telephone+Drug intervention

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

hospital-based population

You may qualify if:

• current smoker aged 18 years or above, Chinese,
• agreed to participate in the follow-up and signed an informed consent form.

You may not qualify if:

• cognitively impaired and with severe diseases,
• occasional or daily smoker,
• Disagree and non-signed an informed consent form.

Sponsors & Collaborators

• Chinese PLA General Hospital: lead

Related Publications (1)

• Jiang B, He Y, Zuo F, Wu L, Liu QH, Zhang L, Zhou CX, Cheng KK, Chan SS, Lam TH. Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China. BMJ Open. 2016 Jan 6;6(1):e009381. doi: 10.1136/bmjopen-2015-009381.

  PMID: 26739730 DERIVED

MeSH Terms

Conditions

Smoking Cessation

Interventions

Referral and Consultation; Tobacco Use Cessation Devices; Bupropion; Varenicline

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Intervention Hierarchy (Ancestors)

Professional Practice; Organization and Administration; Health Services Administration; Therapeutics; Propiophenones; Ketones; Organic Chemicals; Benzazepines; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, Fused-Ring; Heterocyclic Compounds; Quinoxalines

Study Officials

• Yao He, MD, PhD

  Institute of Geriatrics, Chinese PLA General Hospital, Beijing, China

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Institute of Geriatrics

Study Record Dates

• First Submitted: August 25, 2013
• First Posted: September 5, 2013
• Study Start: October 1, 2008
• Primary Completion: September 1, 2013
• Study Completion: December 1, 2018
• Last Updated: September 5, 2013

Record last verified: 2013-09